← Back to headlines
ImmunityBio Stock Falls After FDA Warning on Anktiva Ad and Podcast
ImmunityBio's stock declined after the FDA issued a warning regarding an advertisement and podcast related to its drug Anktiva.
24 Mar, 14:08 — 24 Mar, 14:08
Sources
Showing 1 of 1 sources



